Daniel J. Brennan
Former Executive Vice President And Chief Financial Officer
Boston Scientific Corporation · BSX
$6.3M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed March 18, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $661K
- Stock Awards
- $3.4M
- Option Awards
- $950K
- Incentives
- $1.1M
- Other
- $127K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $660,990 | $3,447,272 | $6,282,896 |
| 2024 | $843,146 | $3,261,199 | $6,687,005 |
| 2023 | $801,528 | $2,764,794 | $5,829,147 |
Current Position
- Title
- Former Executive Vice President And Chief Financial Officer
- Ticker
- BSX · NYSE
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed March 18, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0000885725-26-000025.
Other Boston Scientific Executives
Michael F. Mahoney
Chairman Of The Board, President And Chief Executive Officer
Boston Scientific · BSX
$23.5M
FY 2025 · DEF 14A
Jonathan R. Monson
Executive Vice President And Chief Financial Officer
Boston Scientific · BSX
$6.1M
FY 2025 · DEF 14A
Vance R. Brown
Senior Vice President, General Counsel And Corporate Secretary
Boston Scientific · BSX
$3.9M
FY 2025 · DEF 14A
Arthur C. Butcher
Executive Vice President And Group President, Med Surg And Asia Pacific
Boston Scientific · BSX
$6.5M
FY 2025 · DEF 14A
Joseph M. Fitzgerald
Executive Vice President And Group President, Cardiovascular
Boston Scientific · BSX
$8M
FY 2025 · DEF 14A
Jeffrey B. Mirviss
Executive Vice President And President, Peripheral Interventions
Boston Scientific · BSX
$4.2M
FY 2025 · DEF 14A